title: Evaluation of ADVIA 120 CSF assay (Bayer) vs. chamber counting of cerebrospinal fluid specimens.
abstract: The ADVIA 120 cerebrospinal fluid (CSF) assay (Bayer; Bayer Corp., Tarrytown, NY, USA) provides a new, automated analysis of CSF specimens. We evaluated this method by comparing its performance with classic chamber counting and microscopic analysis of CSF samples.
authors.affiliation: Department of Haematology, University Hospital Antwerp, Antwerp, Belgium.
authors.forename: S
authors.initials: S
authors.lastname: Mahieu
authors.forename: F
authors.initials: F
authors.lastname: Vertessen
authors.forename: M
authors.initials: M
authors.lastname: Van der Planken
mesh_terms: D001331:Automation; D001773:Blood Cells / Q000166:cytology*; D002452:Cell Count / Q000295:instrumentation* / Q000592:standards; D002555:Cerebrospinal Fluid / Q000166:cytology*; D004912:Erythrocytes / Q000166:cytology; D006801:Humans; D007958:Leukocyte Count / Q000295:instrumentation / Q000592:standards; D013129:Spinal Puncture